# Optipulse

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optipulse

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.optbio.cn
- Total disclosed funding: $1.5M
- Latest round: Seed (Apr 1, 2021)
- Investors on record: 1

## About

Based in Shenzhen, China, and founded in 2010, Optipulse is a medical device company integrating scientific research, development, production, and sales, with 2,000 square meters of R&D and production space. The founder, Jiahong Tan graduated from McMaster University and has 36 years of experience in the field of biomaterials and medical devices. In December 2022, it received ethical approval from Zhongshan Hospital of Fudan University. 
 
The company focuses on the field of cardiovascular active interventional diagnosis and treatment, arrhythmia, pulse electric field ablation systems, etc.

## Funding rounds

- Seed, Apr 1, 2021, $0.8M — Yushan Partners
- Seed, Jan 1, 2021, $0.8M — Yushan Partners

## Investors

- Yushan Partners (https://capitalatlas.ai/funds/yushan-partners) — Seed